<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The study was designed to examine the significance of colorectal metachronous <z:mp ids='MP_0002038'>carcinoma</z:mp> in a large cohort of patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Over a mean follow-up period of 10 years, the clinicopathological features, microsatellite instability (MSI) and clinical follow-up of 56 patients with metachronous colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> were analysed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The prevalence of metachronous colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> was 2.1 % </plain></SENT>
<SENT sid="3" pm="."><plain>The metachronous colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> appeared between 7 and 246 months (mean = 66 months) after surgical resection of the index colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-six per cent (n = 20) of the metachronous <z:mp ids='MP_0002038'>carcinoma</z:mp> occurred more than 5 years after the operation of the index <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 56 patients, 20 % (n = 11) of the metachronous colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> were mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancers</z:e> detected in the secondary operations (metachronous colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>), when compared with the primary index <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, were smaller, showed higher proportions of mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and more often located in the proximal colon </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with metachronous <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> had higher prevalence of mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, loss of staining for MSI markers and better survival rates than other patients with <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Patients with metachronous colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> have characteristic features, and attention to these features is important for better management of this group of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>